Search Results

Answer created by AI

Like
Disike

AI result is experimental

Generating Answer...

Source articles

Drug Manufacturers (8874)
Technology (5843)
Therapy Area (5831)
Clinical Trials (4447)
Covid-19 (3955)
Supply Chain (2511)
Infectious Disease (1508)
Regulation (1473)
Oncology (1439)
Drug Development (1406)
deal (1197)
Foreign Direct Investment (1075)
Impact of Chinas Zero COVID lockdowns (868)
Covid-19 Executive Briefing (735)
Approvals (726)
Sponsored (513)
Treatments (429)
Cytiva Pipe dream to pipeline WP 3 (387)
Artificial Intelligence (361)
Suvoda WP (356)

News Analysis and Comments (40310)
Press Releases (3642)
White Papers (1105)
Supplier Products (948)
Projects (771)
Suppliers (761)
post_tag (733)

Clinical IT Systems (92)
Contract Manufacturers (69)
Lab Equipment (69)
Supply Chain (64)
Clinical Trials (55)
Pharmaceutical & Healthcare Packaging (50)
Process Automation and Equipment (43)
Drug Delivery Systems (40)
Clean Rooms and Cleanroom Flooring (38)
API Manufacturers (28)
Purification and Filtration (19)
API Biologics (Cell, Gene, Vaccine) (18)
Diagnostic Imaging (18)
Solid Dose Manufacturing (18)
Commercial Packaging (17)
Pharmaceutical Logistics and Supply Chain (16)
Cloud (15)
Pharma Benefit (14)
Clinical Packaging (13)
Injectables (commercial dose) (13)

United States (4723)
Europe (1590)
United Kingdom (1467)
North America (992)
Global (648)
China (623)
Asia-Pacific (476)
Japan (346)
Canada (246)
Germany (246)
Switzerland (235)
India (228)
UK (158)
France (141)
Australia (135)
US (106)
Russia (101)
South Korea (97)
Middle East and Africa (96)
Denmark (87)

Bristol-Myers Squibb (298)
Merck (258)
Pfizer (256)
AstraZeneca (249)
F. Hoffmann-La Roche (195)
Novartis (190)
AbbVie (165)
Eli Lilly and Co (159)
BeiGene (143)
GSK (126)
Amgen (119)
Gilead Sciences (114)
Johnson & Johnson (114)
Boehringer Ingelheim International (106)
Daiichi Sankyo (97)
Exelixis (86)
Incyte (86)
Sanofi (85)
Regeneron Pharmaceuticals (84)
Takeda Pharmaceutical (83)

Acinetobacter Infections (1)
Acne Vulgaris (1)
Acquired Hemophilia A (1)
Acute Ischemic Stroke (1)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (1)
Acute Sensorineural Hearing Loss (1)
Adrenomyeloneuropathy (AMN) (1)
Alcoholic Hepatitis (1)
Alpha Thalassaemia (1)
Alzheimer's Disease (5)
Amyloidosis (1)
Amyotrophic Lateral Sclerosis (2)
Anaphylaxis (1)
Androgenic Alopecia (1)
Anosmia (1)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) (1)
Anxiety Disorders (1)
Asthma (5)
Ataxia (1)
Atherosclerosis (1)

(Aceclidine + brimonidine) (1)
(Acetaminophen + naltrexone) (2)
(Acetaminophen + nefopam hydrochloride) (1)
(Acetazolamide + dronabinol) (1)
(Amlodipine + fimasartan potassium) (1)
(Amlodipine + indapamide + telmisartan) (1)
(Arginine + sodium succinate) (1)
(Atezolizumab + tiragolumab) (1)
(Atorvastatin + ezetimibe) (1)
(Atorvastatin + fluconazole + minocycline) (2)
(Avibactam sodium + aztreonam) (8)
(Avibactam tomilopil + ceftibuten) (1)
(Azacitidine + cedazuridine) (3)
(Balcinrenone + dapagliflozin) (1)
(Benzoyl peroxide + tretinoin) (1)
(Bizalimogene ralaplasmid + Mavilimogene ralaplasmid) (1)
(Bizalimogene ralaplasmid + mavilimogene ralaplasmid) (1)
(Borneol + edaravone) (1)
(CST-2032 + nadolol) (3)
(Cagrilintide + semaglutide) (2)

Artificial Intelligence (10)
Big Data (3)
Biosimilars (5)
Blockchain (1)
Cell & Gene Therapy (13)
Chemotherapy (1)
Cloud (1)
Corporate Governance (3)
Covid-19 (5)
Cybersecurity (4)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (6)
Future of Work (3)
Genomics (10)
Health & Wellness (1)
Immuno-oncology (19)
Immunotherapy (1)

Showing 20 results out of 10000

Partner Content

Five major cybersecurity challenges all connected organisations need to know about

The convergence of IT (Information Technology) and OT (Operational Technology) is a strong example of how connection opens the door…

Cities

Race is on to claim share of biomanufacturing market

Covid-19 caused increased investment in the biopharmaceutical sector. Now, countries are carving out a place in the multi-billion-dollar market.

Partner Content

Small molecule API: Shining a spotlight on new innovations in milling

Specialist small molecule API services are rising in demand as global appetite for novel therapies and treatments grow. This is putting third-party pharmaceutical mill providers and their capabilities in the spotlight.

Partner Content

Why data management and decision-making go hand-in-hand in clinical research

The pharmaceutical industry is fuelled by data. Huge amounts of information are available from sources as diverse as patient health…

Partner Content

A winning combination: The benefits of micronization and containment in a single installation

As more small-molecule, high-potency APIs (HPAPIs) gain approval, the advantage will go to those CMOs that have combined containment and micronization facilities.

Partner Content

From security risk to firewall: Nymi’s connected worker paradigm for the pharma sector

Nymi, with its ultra-secure, Zero Trust Connected Worker Platform, is determined to provide pharmaceutical companies with answers to issues raised…

Partner Content

Fixed-dose combination: Considerations for design, formulation, manufacturing and analysis

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development…

Partner Content

The Canadian life sciences hub that may not be on your FDI radar (but should be)

Investment Monitor explores the vibrant and emerging life sciences scene in Hamilton, Ontario.

Cities

Life science recruitment expert explains how Charleston is attracting top talent from across the globe

Investment Monitor spoke to Joyce De Leo, PhD, executive search consultant at WittKieffer, on why Charleston, SC, is on track to become the next epicentre for US life sciences, including her own experiences relocating and recruiting to the region.

Features

Why this global life sciences COO believes relocation to Charleston was key to achieving next-level success

After visiting 100 potential sites across eight different states, nutraceutical company Thorne HealthTech began a huge relocation to Charleston, SC, in 2014 and has never looked back. Here, Thorne COO Tom McKenna explains what drove its decision and subsequent success.

Cities

What factors are driving life sciences FDI in 2022?

Investment Monitor explores top drivers for greenfield FDI in the life sciences, including examples from Charleston, South Carolina – a mid-sized US metro that is ripe for investment.

New technologies fuel advancements in digital health

AI, the internet of things and more are fuelling a new generation of medical services and products that improve patient outcomes and reduce healthcare costs.

Partner Content

Optimising biopharma production through process intensification

Process intensification has long been viewed in biopharma production as a means to increase production efficiency and reduce costs. Yet the pathway there is not always straightforward, there are a number of approaches that can be taken. New technologies are pivotal in delivering advances in process intensification, and we learn more about how the 3M™ Harvest RC Chromatographic Clarifier can achieve this.

Partner Content

Software as a Medical Device: Why companion apps are a growing MedTech trend

Remote Patient Monitoring, incorporated within mobile health apps, is increasingly prescribed alongside traditional treatments. MedTech companies are looking to expand their scope of influence with patients and providers by partnering with professional, regulated companion apps.

Partner Content

Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing

In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While…

Partner Content

Pharmaceutical companies benefit from the NYMI Connected Worker Platform

How does NYMI help pharmaceutical companies empower their workforces and connect to their corporate digital infrastructure seamlessly? In the last…

Partner Content

The Nymi Connected Worker Platform – how does it work?

To understand how the Nymi Connected Worker Platform unifies modern businesses, we need to delve into the constituent technologies that…

Partner Content

Connected workers: Using passwordless wearable identity to integrate with the digital workplace

The integration of Internet of Things (IoT) technology across the pharmaceutical supply chain has allowed for greater visibility and traceability…

Partner Content

How connected workers in pharma can improve data integrity, compliance and efficiency

Incorporating workers into your organization’s digital transformation/IoT journey benefits everyone – employers and employees Three primary advantages pharmaceutical companies hope…

Partner Content

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Although orphan drugs are developed to address the unmet medical needs of rare disease patients, traditional launch strategies have failed to deliver widespread access. But is there a lucrative yet underserved market and patient population hidden just outside of the EU-5?